Nuclear Hormone Receptor Activity of Polybrominated Diphenyl Ethers and Their Hydroxylated and Methoxylated Metabolites in Transactivation Assays Using Chinese Hamster Ovary Cells
- 1 August 2009
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 117 (8), 1210-1218
- https://doi.org/10.1289/ehp.0900753
Abstract
Background An increasing number of studies are reporting the existence of polybrominated diphenyl ethers (PBDEs) and their hydroxylated (HO) and methoxylated (MeO) metabolites in the environment and in tissues from wildlife and humans. Objective Our aim was to characterize and compare the agonistic and antagonistic activities of principle PBDE congeners and their HO and MeO metabolites against human nuclear hormone receptors. Methods We tested the hormone receptor activities of estrogen receptor α (ERα), ERβ, androgen receptor (AR), glucocorticoid receptor (GR), thyroid hormone receptor α1 (TRα1), and TRβ1 against PBDE congeners BDEs 15, 28, 47, 85, 99, 100, 153, and 209, four para-HO-PBDEs, and four para-MeO-PBDEs by highly sensitive reporter gene assays using Chinese hamster ovary cells. Results Of the 16 compounds tested, 6 and 2 showed agonistic activities in the ERα and ERβ assays, respectively, and 6 and 6 showed antagonistic activities in these assays. 4′-HO-BDE-17 showed the most potent estrogenic activity via ERα/β, and 4′-HO-BDE-49 showed the most potent anti estrogenic activity via ERα/β. In the AR assay, 13 compounds showed antagonistic activity, with 4′-HO-BDE-17 in particular inhibiting AR-mediated transcriptional activity at low concentrations in the order of 10−8 M. In the GR assay, seven compounds, including two HO-PBDEs and two MeO-PBDEs, showed weak antagonistic activity. In the TRα1 and TRβ1 assays, only 4-HO-BDE-90 showed weak antagonistic activity. Conclusions Taken together, these results suggest that PBDEs and their metabolites might have multiple endocrine-disrupting effects via nuclear hormone receptors, and para-HO-PBDEs, in particular, possess more potent receptor activities compared with those of the parent PBDEs and corresponding para-MeO-PBDEs.Keywords
This publication has 53 references indexed in Scilit:
- Hydroxylated Metabolites of Polybrominated Diphenyl Ethers in Human Blood Samples from the United StatesEnvironmental Health Perspectives, 2009
- Hydroxylated Metabolites of the Polybrominated Diphenyl Ether Mixture DE-71 Are Weak Estrogen Receptor-α LigandsEnvironmental Health Perspectives, 2008
- Measurement of Polybrominated Diphenyl Ethers and Metabolites in Mouse Plasma after Exposure to a Commercial Pentabromodiphenyl Ether MixtureEnvironmental Health Perspectives, 2007
- The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor ActivatorsToxicological Sciences, 2007
- Steroid receptor profiling of vinclozolin and its primary metabolitesToxicology and Applied Pharmacology, 2006
- Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosisLife Sciences, 2005
- Synthesis of Hydroxylated and Methoxylated Polybrominated Diphenyl Ethers − Natural Products and Potential Polybrominated Diphenyl Ether MetabolitesEuropean Journal of Organic Chemistry, 2003
- Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.Environmental Health Perspectives, 1999
- Polybrominated diphenyl ethers and hexabromocyclododecane in sediment and fish from a Swedish RiverEnvironmental Toxicology and Chemistry, 1998
- Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonistNature, 1995